tiprankstipranks
Trending News
More News >
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market

Catalyst Pharma (CPRX) Technical Analysis

Compare
2,308 Followers

Technical Sentiment

Overall Consensus
Sell
8Bullish
2Neutral
12Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Catalyst Pharma’s (CPRX) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Catalyst Pharma is a Buy.
Catalyst Pharma’s (CPRX) 20-Day exponential moving average is 24.51, while Catalyst Pharma’s (CPRX) share price is $23.22, making it a Sell.
Catalyst Pharma’s (CPRX) 50-Day exponential moving average is 24.07, while Catalyst Pharma’s (CPRX) share price is $23.22, making it a Sell.

Catalyst Pharma (CPRX) Pivot Points

Jun 19, 2025, 03:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
22.88
23.14
23.40
23.66
23.92
24.18
24.44
Fibonacci
23.14
23.34
23.46
23.66
23.86
23.98
24.18
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Catalyst Pharma (CPRX) Moving Averages

Jun 19, 2025, 03:17 AM
Period
Simple
Exponential
MA5
24.02Sell
23.95Sell
MA10
24.88Sell
24.41Sell
MA20
24.76Sell
24.51Sell
MA50
23.83Sell
24.07Sell
MA100
23.30Sell
23.35Sell
MA200
22.28Buy
21.96Buy
Catalyst Pharma’s (CPRX) 10-Day exponential moving average is 24.41, while Catalyst Pharma’s (CPRX) share price is $23.22, making it a Sell.
Catalyst Pharma’s (CPRX) 100-Day exponential moving average is 23.35, while Catalyst Pharma’s (CPRX) share price is $23.22, making it a Sell.
Catalyst Pharma’s (CPRX) stock price is $23.22 and Catalyst Pharma’s (CPRX) 50-day simple moving average is 23.83, creating a Sell signal.
Catalyst Pharma’s (CPRX) stock price is $23.22 and Catalyst Pharma’s (CPRX) 100-day simple moving average is 23.30, creating a Sell signal.
Catalyst Pharma’s (CPRX) stock price is $23.22 and Catalyst Pharma’s (CPRX) 200-day simple moving average is 22.28, creating a Buy signal.

Catalyst Pharma (CPRX) Technical Indicators

Jun 19, 2025, 03:17 AM
Name
Value
Implied Action
RSI (14)
38.95
Neutral
STOCH (9,6)
7.69
Buy
STOCHRSI (14)
7.69
Buy
MACD (12,26)
0.03
Buy
ADX (14)
17.86
Buy
Williams %R
-97.96
Buy
CCI (14)
-154.26
Buy
ATR (14)
0.85
-
Ultimate Oscillator
37.59
Neutral
ROC
-5.38
Sell
Catalyst Pharma’s (CPRX) Relative Strength Index (RSI) is 38.95, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Trend Strength Indicator (ADX) is 17.86, creating a Buy signal.
Catalyst Pharma’s (CPRX) Commodity Channel Index (CCI) is -154.26, creating a Buy signal.
Catalyst Pharma’s (CPRX) Price Rate of Change (ROC) is -5.38, creating a Sell signal.

FAQ

Is CPRX a Buy, Hold, or Sell?
Based on CPRX’s technical indicators, CPRX is a Sell.
    What is CPRX’s RSI (14)?
    CPRX’s RSI (14) is 38.95, which suggests CPRX is a Neutral.
      What is CPRX’s MACD?
      CPRX’s MACD is 0.03, which suggests CPRX is a Buy.
        What is CPRX’s 5-day moving average?
        CPRX’s 5-day moving average is 24.02, which suggests CPRX is a Sell.
          What is CPRX’s 20-day moving average?
          CPRX 20-day moving average is 24.76, which suggests CPRX is a Sell.
            What is CPRX’s 50-day moving average?
            CPRX’s 50-day moving average is 23.83, which suggests CPRX is a Sell.
              What is CPRX’s 200-day moving average?
              CPRX’s 200-day moving average is 22.28, which suggests CPRX is a Buy.
                What is CPRX’s Williams % R (14)?
                CPRX’s Williams % R (14) is -97.96, which suggests CPRX is a Buy.
                  What is CPRX’s CCI (14)?
                  CPRX’s CCI (14) is -154.26, which suggests CPRX is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis